ALLOSOURCE® ANNOUNCES 200TH IMPLANT OF ACECONNEX® PRE-SUTURED FASCIA DEVICE FOR HIP LABRAL RECONSTRUCTION AND AUGMENTATION
CENTENNIAL, Colo., March 27, 2025 /PRNewswire/ -- AlloSource, a life sciences organization that helps restore patient functionality by transforming the gift of human tissue donation into enhanced medical products, today announced the 200th implant of AceConnex Pre-Sutured Fascia. The device is the only 510(k) cleared pre-sutured fascia allograft for hip labral reconstruction and augmentation.
"Having used AceConnex Pre-Sutured Fascia, I believe it answers an unmet need to better support surgeons performing hip labral reconstruction and augmentation," said Dr. Andrew Jimenez, a sports and hip preservation surgeon at Yale University. "I appreciate the quality and consistency of AceConnex, which helps me take better care of my patients."
AceConnex being pre-sutured ensures consistency and minimizes variability compared to allografts sutured in the operating room. AceConnex Pre-Sutured Fascia is intended for use as a component in soft tissue surgical procedures where constructs, including those with allograft tissue, are used for reconstructing or augmenting the labrum. It is ready-to-use, eliminating the time required to suture in an already time-consuming reconstruction procedure.
"The AceConnex labral graft continues to streamline and simplify my labral reconstruction practice by eliminating the graft preparation process from the procedure. The graft comes prepared and pre-sutured, out of the box, and handles and looks great in the joint. It is ready when I need it and has been a real game-changer for me," said Dr. Winston Gwathmey, orthopedic surgeon specializing in sports medicine and arthroscopy of the shoulder, hip and knee at the University of Virginia.
AceConnex Pre-Sutured Fascia is available in three trimmable lengths to support segmental and circumferential labral reconstruction procedures. Each device can be trimmed to fit the specific sizing needs of the surgeon and patient. In addition, each length comes in two different diameters.
"We created AceConnex Pre-Sutured Fascia to help streamline hip arthroscopy," said Dean Elliott, AlloSource President and CEO. "This 200-implant milestone is one step in our goal to provide innovative solutions that help surgeons more easily perform complex hip arthroscopy procedures."
For more information on new AceConnex Pre-Sutured Fascia please, visit allosource.org/products/aceconnex.
About AlloSource
AlloSource, a life sciences organization, helps restore patient functionality by transforming the gift of human tissue donation into enhanced medical products that enable a life of movement, health, and wellbeing. The organization partners with medical professionals and biomedical companies who share our drive for innovation and quality in the use of human tissue allografts for medical advancements. Headquartered in Centennial, Colorado, AlloSource has served a global marketplace since 1994. Learn more at allosource.org.
Media Contact
Cindy Mason
AlloSource
720. 873. 0213
cmason@allosource.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/allosource-announces-200th-implant-of-aceconnex-pre-sutured-fascia-device-for-hip-labral-reconstruction-and-augmentation-302413526.html
SOURCE AlloSource